GI Surgery – Liver
Cohort Study: Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases.
6 Apr, 2022 | 10:23h | UTCCommentaries:
Living-Donor Liver Transplant Promising for CRC With Liver Mets – HealthDay
Commentary on Twitter
Study suggests living-donor liver transplant is a promising option for meticulously selected patients with unresectable colorectal cancer liver metastases. https://t.co/p6Jbzb73DL
— JAMA Surgery (@JAMASurgery) March 30, 2022
Review: Surgical risk assessment in patients with chronic liver diseases.
25 Mar, 2022 | 08:46h | UTC
Commentary on Twitter
Surgical Risk Assessment in Patients With Chronic Liver Diseases https://t.co/us01T2XsxE
— Journal of Clinical and Experimental Hepatology (@JCEH_Hepatology) March 23, 2022
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
21 Mar, 2022 | 10:01h | UTC
RCT: Effect of early vs. late supplemental parenteral nutrition in patients undergoing abdominal surgery.
17 Mar, 2022 | 08:43h | UTCInvited Commentary: Early Postoperative Supplementary Parenteral Nutrition – JAMA Surgery
Author Interview: Supplemental Parenteral Nutrition in Patients Undergoing Abdominal Surgery
Commentary on Twitter
Randomized clinical trial found supplemental parenteral nutrition in combination with enteral nutrition could significantly reduce the incidence of nosocomial infections in patients undergoing abdominal surgery. https://t.co/Agbf9TKPfX
— JAMA Surgery (@JAMASurgery) March 16, 2022
A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
16 Mar, 2022 | 08:37h | UTC
Case report: Nonthrombotic pulmonary embolism secondary to cyanoacrylate embolization of gastric varices.
8 Mar, 2022 | 08:35h | UTC
Ten myths about albumin.
7 Mar, 2022 | 00:44h | UTCTen myths about albumin – Intensive Care Medicine (free for a limited period)
Commentary on Twitter
Albumin, 10 myths
1️⃣leaks into interstitium
2️⃣ ⬇️volume expansion vs artificial colloids
3️⃣ ⬇️AKI
4️⃣ sepsis: ⬆️survival
5️⃣ ⬆️diuretics effects
6️⃣RRT: ⬆️ fluid removal
7️⃣cirrhosis: ⬇️mortality
8️⃣TBI: ⬆️mortality
9️⃣correcting hypoalb ⬇️mortality
🔟 ⬆️NaCl
📎 https://t.co/nGOHOLYRqY pic.twitter.com/YroygQNNUk— Intensive Care Medicine (@yourICM) March 5, 2022
M-A: Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma.
7 Mar, 2022 | 00:07h | UTC
Commentary from the author on Twitter (thread – click for more)
In this global study of NAFLD-related HCC, we determine:
1.Prevalence
2.Clinical characteristics
3.% cirrhosis
4.Surveillance
5.Treatment allocation
6.Outcomes#LiverCancerSIG #LivertwitterFree to read @TheLancetOncol https://t.co/vwAeicpWxq
1/n pic.twitter.com/gM1BHVSwXl
— Daniel Huang (@DrHuangDQ) March 4, 2022
Surgical considerations regarding transplantation for the patient with acute-on-chronic liver failure.
16 Feb, 2022 | 08:28h | UTC
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.
15 Feb, 2022 | 09:56h | UTCRelated:
A consensus integrated care pathway for patients with primary biliary cholangitis.
Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and its Complications
Comprehensive imaging characterization of colorectal liver metastases.
13 Feb, 2022 | 21:27h | UTCComprehensive Imaging Characterization of Colorectal Liver Metastases – Frontiers in Oncology
Review: Advance care planning and goals of care discussions in advanced liver disease.
2 Feb, 2022 | 08:17h | UTC
RCT: Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant.
1 Feb, 2022 | 08:58h | UTCCommentaries:
Normothermic Machine Perfusion Improves Outcomes in Liver Transplant Recipients – Physician’s Weekly
Machine Perfusion Cuts Early Graft Dysfunction in Liver Transplantation – MedPage Today (free registration required)
Related:
RCT: Hypothermic machine perfusion in liver transplantation
Transplantation of Discarded Livers Following Viability Testing with Normothermic Machine Perfusion
Commentaries on Twitter
Study found portable normothermic oxygenated machine perfusion of donor liver grafts resulted in improved outcomes of liver transplantation and in more livers being transplanted. https://t.co/PZzvFriJvB pic.twitter.com/2icSfxoLDF
— JAMA Surgery (@JAMASurgery) January 5, 2022
Study found portable normothermic oxygenated machine perfusion of donor liver grafts resulted in improved outcomes of liver transplantation and in more livers being transplanted. https://t.co/TKEsTf8Htu pic.twitter.com/tg2xDGDyOS
— JAMA Surgery (@JAMASurgery) January 5, 2022
Consensus statement on hemostatic management, anticoagulation, and antiplatelet therapy in liver transplantation.
20 Jan, 2022 | 08:47h | UTC
Review: Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation.
3 Nov, 2021 | 09:45h | UTC
Commentary on Twitter
New content online: Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation https://t.co/sWd1Vs6N2c pic.twitter.com/XZo8ETzhEl
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) November 2, 2021
Consensus Guideline: Liver transplantation for non-resectable colorectal liver metastases.
16 Sep, 2021 | 09:50h | UTCLiver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines – The Lancet Gastroenterology & Hepatology (free registration required)
Commentary on Twitter
New online – Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelineshttps://t.co/oZL4X4h7VS@IHPBA @gbonneysurg @eahpba @_ilts_#livertwitter #APHPBA_2021 pic.twitter.com/g6rrVclV5h
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 8, 2021
Podcast: The Best of Liver Tests.
7 Sep, 2021 | 10:29h | UTC#293 The Best of Liver Tests with Dr. Elliot Tapper – The Curbsiders
Global burden of cancer attributable to alcohol consumption – “Globally, an estimated 741.300, or 4·1% of all new cases of cancer in 2020 were attributable to alcohol consumption”.
14 Jul, 2021 | 11:07h | UTCNews release: Alcohol consumption linked to more than 740,000 new cancer cases in 2020 – The Lancet
Commentaries: Alcohol caused 740,000 cancer cases globally last year – study – The Guardian AND Expert reaction to study of alcohol and cancer – Science Media Centre
AASLD Guideline: Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease.
28 Jun, 2021 | 09:33h | UTC
Guide to Enhanced Recovery for Cancer Patients Undergoing Liver Surgery
25 Apr, 2021 | 20:53h | UTCSee also: Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations – World Journal of Surgery AND Enhanced Recovery After Surgery (ERAS) Society Guidelines
Systematic review: Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
23 Apr, 2021 | 08:17h | UTC
M-A: Treatment for bleeding esophageal varices in people with decompensated liver cirrhosis
12 Apr, 2021 | 00:39h | UTCRelated Cochrane Reviews: M-A: Secondary prevention of variceal bleeding in adults with previous esophageal variceal bleeding due to decompensated liver cirrhosis AND Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis – Cochrane Library
Meta-Analysis: Primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis
8 Apr, 2021 | 08:45h | UTCRelated Cochrane Review: M-A: Secondary prevention of variceal bleeding in adults with previous esophageal variceal bleeding due to decompensated liver cirrhosis
M-A: Secondary prevention of variceal bleeding in adults with previous esophageal variceal bleeding due to decompensated liver cirrhosis
5 Apr, 2021 | 01:17h | UTC
RCT: Mixed findings with Terlipressin plus Albumin for the treatment of Type 1 hepatorenal syndrome
4 Mar, 2021 | 08:35h | UTCTerlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome – New England Journal of Medicine (link to abstract – $ for full-text)